Pediculosis treatment product news Jan 2015

A summary of recent pediculosis product news.

Derbac M sold to Lanes Health

Lanes Health, a UK company with a broad prospectus of health products, has recently negotiated the purchase of the rights to Derbac M, the malathion-based pediculosis treatment, from Reckitt Benckiser.

Natroba age-indication reduced

ParaPRO recently announced that the US Food and Drug Administration has reduced the age-indication for its Natroba pediculosis treatment down to six months.

Natroba received FDA approval in 2011 for treatment in children four years of age and older.

New Numark 1% treatment

Numark have recently released their Numark Head Lice Treatment 1%, a permethrin-based pediculosis treatment.